Compare ZEUS & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZEUS | BIOA |
|---|---|---|
| Founded | 1954 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 388.6M | 443.9M |
| IPO Year | 1994 | 2024 |
| Metric | ZEUS | BIOA |
|---|---|---|
| Price | $45.01 | $13.21 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $38.00 | $13.50 |
| AVG Volume (30 Days) | 116.5K | ★ 476.3K |
| Earning Date | 10-28-2025 | 11-06-2025 |
| Dividend Yield | ★ 1.44% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.17 | N/A |
| Revenue | ★ $1,898,863,000.00 | $5,917,000.00 |
| Revenue This Year | $0.48 | N/A |
| Revenue Next Year | $2.77 | N/A |
| P/E Ratio | $37.88 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $26.32 | $2.88 |
| 52 Week High | $45.41 | $13.68 |
| Indicator | ZEUS | BIOA |
|---|---|---|
| Relative Strength Index (RSI) | 71.55 | 74.39 |
| Support Level | $42.62 | $12.00 |
| Resistance Level | $45.41 | $13.68 |
| Average True Range (ATR) | 1.60 | 0.83 |
| MACD | 0.19 | 0.05 |
| Stochastic Oscillator | 95.47 | 88.77 |
Olympic Steel Inc provides metals processing and distribution services in the United States. The company operates in three reportable segments; specialty metals flat products, carbon flat products, and tubular and pipe products. It specializes in the processing and distribution of large volumes of carbon, aluminum, and stainless steel flat-rolled sheet, coils, plates, bars, and fabricated parts. The group serves various industries such as industrial machinery and equipment manufacturers, automobile manufacturers and suppliers, and transportation equipment manufacturers. The company generates majority of the revenue from carbon flat products.
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.